Related Experiment Video
Updated: Jul 9, 2026

A Minimally Invasive Model of Aortic Stenosis in Swine
Published on: October 20, 2023
Timing of operation in asymptomatic severe aortic stenosis
Hari P Chaliki1, Morgan L Brown, Thoralf M Sundt
1Mayo Clinic Arizona, Division of Cardiovascular Diseases, 13400 E. Shea Boulevard, Scottsdale, AZ 85255, USA. chaliki.hari@mayo.edu
Insights
Calcific aortic stenosis is the leading cause of aortic stenosis, often managed with surgery for symptomatic patients. Early surgery may benefit select asymptomatic individuals with severe stenosis.
Area of Science:
- Cardiology
- Valvular Heart Disease
Background:
- Calcific aortic stenosis (CAS) is now the primary cause of aortic stenosis, surpassing rheumatic fever.
- Hyperlipidemia is a significant risk factor contributing to the progression of CAS.
Purpose of the Study:
- To review the current understanding and management of calcific aortic stenosis.
- To identify patient subgroups who may benefit from early surgical intervention.
Main Methods:
- Review of current American College of Cardiology/American Heart Association guidelines for severe aortic stenosis.
- Analysis of factors indicating severity: peak velocity > 4 m/sec, mean gradient > 40 mmHg, valve area < 1.0 cm(2).
- Evaluation of indicators for early surgery in asymptomatic patients, including aortic valve calcium and exercise testing.
Main Results:
- Severe aortic stenosis is defined by specific hemodynamic criteria.
- Symptomatic patients with severe aortic stenosis have a poor prognosis without timely aortic valve surgery.
- Asymptomatic patients with high aortic valve calcium or positive exercise tests may benefit from early surgery.
Conclusions:
- Aortic valve surgery offers low risk and improved outcomes for selected asymptomatic patients with severe CAS due to advancements in techniques and prosthetics.
- Percutaneous aortic valves are currently indicated for very high-risk symptomatic patients, with potential for expanded use.
- Future molecular cardiology advancements may offer novel preventative therapies for CAS.
Abstract:
Calcific aortic stenosis is now the main cause of aortic stenosis in the majority of patients, due to declining incidence of rheumatic fever. Risk factors such as hyperlipidemia play an important role in the progression of aortic stenosis. According to the most recent American College of Cardiology/American Heart Association guidelines, peak velocity greater than 4 m/sec, a mean gradient of more than 40 mmHg and a valve area of less than 1.0 cm(2) is considered hemodynamically severe aortic stenosis. Aortic valve surgery promptly should be done in symptomatic patients due to dismal prognosis without operation. Features such as high aortic valve calcium and positive exercise test identify asymptomatic patients who would benefit from early aortic valve surgery. Due to improvement in surgical techniques and better prosthesis, aortic valve surgery can now be offered at low risk to a selected group of asymptomatic patients with severe aortic stenosis. Currently percutaneous aortic valves are used in very high-risk patients with severe symptomatic aortic stenosis. Their role may expand in the future, depending on the improvements in design and operator experience. Whether advances in molecular cardiology lead to novel therapies in preventing calcific aortic stenosis in the future remains to be seen.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Mitral Stenosis III: Medical Management
Aneurysm IV: Nursing Management
Aneurysm III: Interprofessional Care

